Latest Headlines

2017 | 2016 | 2015 | 2014 | 2013 | 2012

March 2017

“One-stop shop” family planning more effective for women living with HIV

UCSF Bixby Center
Bixby Center researchers have released the first study to show that integrating HIV care and family planning services reduces the pregnancy rate among women living with HIV in Kenya—by nearly 30 percent.

Making birth control pills available OTC could benefit teens most

UCSF Bixby Center
A new review of oral contraceptive (OC) research renews and strengthens the case for making OC available over-the-counter—with a focus on the potential benefits for adolescents.

Diana Greene Foster wins Society of Family Planning mentor award

UCSF Bixby Center
Congratulations to UCSF Bixby Center member Diana Greene Foster, PhD on receiving the Society of Family Planning's Robert A. Hatcher Family Planning Mentor Award.

Analyzing disparities in postpartum care and contraception

UCSF Bixby Center
A new study identifies disparities in the care and contraception that postpartum low-income women in California receive.

Access to most effective birth control could save $12 billion a year

Time
Using data from a 2015 study on birth control access by Bixby researchers, the Brookings Institute and Child Trends produced a report estimating the impact and cost savings that would result from every woman having full access to the most effective contraceptive methods.

Shaping policy with science: Highlights from the Bixby symposium

UCSF Bixby Center
On March 2, the one-year anniversary of the Supreme Court hearing Whole Woman’s Health v. Hellerstedt, the Bixby Center and BIRCWH convened a symposium focused on science’s role in shaping policy.

New tool brings shared decision-making to contraceptive counseling

UCSF Bixby Center
Nearly half of pregnancies in the U.S. are unintended, and many result from people failing to use contraception correctly or consistently. One way to improve contraceptive use is to help women select contraceptive methods that better accommodate their personal preferences.

February 2017

A call to end the excessive regulation of mifepristone

UCSF Bixby Center
In a recent New England Journal of Medicine commentary, a group of experts including the Bixby Center’s Dr. Daniel Grossman called on the FDA to eliminate the FDA's excessive regulation of the medication abortion drug mifepristone.

Barriers to offering vasectomy at publicly funded family planning organizations

UCSF Bixby Center
A recent study co-authored by Daniel Grossman, MD interviewed administrators at publicly funded family planning organizations in Texas to identify barriers to offering vasectomy.

Sixteen years of overregulation: Time to unburden Mifeprex

The New England Journal of Medicine
A group of experts, including Daniel Grossman, MD, director of ANSIRH and Bixby Center member, calls for an end to the FDA's overregulation of Mifeprex (mifepristone), a drug commonly used in medication abortions.